U.S. Gene Editing Market Size & Outlook, 2026-2033

Name: U.S. Gene Editing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The gene editing market in the United States is expected to reach a projected revenue of US$ 9,379.2 million by 2033. A compound annual growth rate of 15.9% is expected of the United States gene editing market from 2026 to 2033.

Biotechnology
- Genomics & Genetic Engineering
  - Gene Editing Market Outlook

U.S. gene editing product outlook (Revenue, USD million, 2021-2033)
- Reagents and Consumables
- Software and Systems
- Services
U.S. gene editing technology outlook (Revenue, USD million, 2021-2033)
- CRISPR-Cas System
- Transcription Activator-Like Effector Nucleases (TALENs)
- Zinc Finger Nucleases (ZFNs)
- Meganucleases/Homing Endonucleases
U.S. gene editing end use outlook (Revenue, USD million, 2021-2033)
- Biotechnology and Pharmaceutical Companies
- University and Research Institutes
- Other

U.S. Gene Editing Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!